Interim no more: Ashley Magargee to fill Genentech CEO post; Pfizer, Moderna make commercial leadership adjustments

Ashley Magargee

Ashley Magargee will become the CEO of Genentech on Jan. 1, two decades into her tenure at the South San Francisco biotech pioneer, which she joined prior to its $47 billion deal with now-parent Roche.

She’s held the interim…
Click here to view original post